プレシジョンメディシンの世界市場2020-2030

visiongainが発行した調査報告書(VGA20DE049)
◆英語タイトル:Precision Medicine Market Report 2020-2030
◆商品コード:VGA20DE049
◆発行会社(リサーチ会社):visiongain
◆発行日:2020年5月
◆ページ数:375
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Sigle User(1名様閲覧用)USD5,069 ⇒換算¥557,590見積依頼/購入/質問フォーム
Global Site License(法人閲覧用)USD9,099 ⇒換算¥1,000,890見積依頼/購入/質問フォーム
※visiongain社発行の調査レポートは、Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。

販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongain社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。visiongain社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Precision Medicine–our new study reveals trends, R&D progress, and predicted revenues
Where is the Precision Medicine market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead

Our 375 pages report provides 271 tables, 267 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Precision Medicine Market. See how to exploit the opportunities.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

Forecasts to 2030 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets

Along with revenue prediction for the overall world market, there are following segments, each forecasted at a global and regional level.

Precision Medicine Market by Therapeutics
• Cancer
• Cardiovascular
• Central Nervous System
• Infectious Diseases
• Immunology
• Others
Precision Medicine Market by Technology
• Companion Diagnostics
• Biomarkers
• Biobanking in Targeted Therapeutics
• Pharmacogenomics
• Molecular Diagnostics
Precision Medicine Market by End Users
• Pharma & Biotech
• Diagnostic Tool Companies
• Healthcare IT/Big Data Companies
• Clinical Laboratories
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 22 leading national markets:

North America
• U.S.
• Canada
Europe
• Germany
• UK
• France
• Italy
• Spain
• Belgium
• Switzerland
• Rest of Europe
Asia Pacific
• Japan
• China
• India
• Australia
• Singapore
• The Philippines
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America
Middle East and Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of MEA
The report also includes profiles and for some of the leading companies in the Precision Medicine market, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth

Overall world revenue for Precision Medicine Market will surpass $67 billion in 2020, our work calculates. We predict strong revenue growth through to 2030.

Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Precision Medicine Market report helps you

In summary, our 375 pages report provides you with the following knowledge:
• Revenue forecasts to 2030 for 5 regional and 22 key national markets– See forecasts for the Precision Medicine market in North America, Latin America, Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Argentina, Germany, France, UK, Italy, Spain, Belgium, Switzerland, China, India, Japan, Australia, Singapore, The Philippines, South Korea. UAE, Saudi Arabia and South Africa.
• Prospects for established firms and those seeking to enter the market– including company profiles for 14 of the major companies involved in the Precision Medicine market i.e. Abbott, GE Healthcare, Johnson & Johnson Services, Inc., Pfizer Inc., Laboratory Corporation of America Holdings, Danaher, Qiagen N.V., Thermo Fisher Scientific Inc., Illumina, Inc., Novartis AG, GSK, Merck KGaA, F. Hoffmann-La Roche Ltd, and Amgen Inc.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

The publisher is using a password system to access all reports. Single user (non-printable) and departmental licenses expires after 12 month period. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.
.

【レポートの目次】

1 Report Overview
1.1 Why You Should Read This Report
1.2 What This Report Delivers
1.3 Key Questions Answered by This Analytical Report Include:
1.4 Who is This Report For?
1.5 Methodology
1.6 Frequently Asked Questions (FAQs)
1.7 Associated Visiongain Reports
1.8 About Visiongain
2 Market Scope: Precision Medicine
2.1 Precision Medicine Market Definition
2.2 Precision Medicine Market: Introduction
2.3 Evolution and Brief History of Precision Medicine
2.4 Key Benefits of Precision Medicine
2.5 Precision Medicine: Key Areas of Application
2.6 Precision Medicine: Key Elements
2.7 Precision Medicine: Different Type of Data Used by Big Data Companies
2.8 Precision Medicine: Area of Interest
3 Global Precision Medicine Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Challenges Faced by Precision Medicine Market
3.1.3 Restraints Faced by Precision Medicine Market
3.1.4 Key Opportunities
3.2 SWOT Analysis
3.2.1 Strengths
3.2.2 Weaknesses
3.2.3 Opportunities
3.2.4 Threats
3.3 Industry analysis – Porter’s
3.3.1 Degree of competition
3.3.2 Supplier power
3.3.3 Buyer power
3.3.4 Threat from substitutes
3.3.5 Threat of new entrants
3.4 Industry analysis – PEST
3.4.1 Political
3.4.2 Economical
3.4.3 Social
3.4.4 Technological
3.5 Value Chain Analysis
3.5.1 Device Manufacturer & Drug Producers
3.5.2 Healthcare Providers
3.5.3 Healthcare IT Or Big Data Companies
3.5.4 Regulators
3.5.5 Third Party Payers
3.5.6 Patients
3.6 COVID-19 Impact Analysis
3.6.1 Role of Precision Medicine
3.6.2 Cancer Patients Assessment and Treatment Priority Determination (Top, Intermediate & Low Priority)
3.6.3 Global Precision Medicine Market Forecast by Therapeutics, (Pre-COVID-19)
3.6.4 Global Precision Medicine Market Forecast by Technology, (Pre-COVID-19)
3.6.5 Global Precision Medicine Market Forecast by End-Users, (Pre-COVID-19)
3.6.6 Global Precision Medicine Market Forecast by Region, (Pre-COVID-19)
4 Global Precision Medicine Market Size Forecast 2020-2030 by Therapeutics
4.1 Cancer
4.1.1 Recovery Forecast, 2020-2030 (V, U, W, L)
4.2 Cardiovascular
4.2.1 Recovery Forecast, 2020-2030 (V, U, W, L)
4.3 CNS
4.3.1 Recovery Forecast, 2020-2030 (V, U, W, L)
4.4 Infectious Diseases
4.4.1 Recovery Forecast, 2020-2030 (V, U, W, L)
4.5 Immunology
4.5.1 Recovery Forecast, 2020-2030 (V, U, W, L)
4.6 Others
4.6.1 Recovery Forecast, 2020-2030 (V, U, W, L)
5 Global Precision Medicine Market Size Forecast 2020-2030 by Technology
5.1 Companion Diagnostics
5.1.1 Recovery Forecast, 2020-2030 (V, U, W, L)
5.2 Biomarkers
5.2.1 Recovery Forecast, 2020-2030 (V, U, W, L)
5.3 Biobanking in Targeted Therapeutics
5.3.1 Recovery Forecast, 2020-2030 (V, U, W, L)
5.4 Pharmacogenomics
5.4.1 Recovery Forecast, 2020-2030 (V, U, W, L)
5.5 Molecular Diagnostics
5.5.1 Recovery Forecast, 2020-2030 (V, U, W, L)
6 Global Precision Medicine Market Size Forecast 2020-2030 by End Users
6.1 Pharma & Biotech
6.1.1 Recovery Forecast, 2020-2030 (V, U, W, L)
6.2 Diagnostic Tool Companies
6.2.1 Recovery Forecast, 2020-2030 (V, U, W, L)
6.3 Healthcare IT/Big Data Companies
6.3.1 Recovery Forecast, 2020-2030 (V, U, W, L)
6.4 Clinical Laboratories
6.4.1 Recovery Forecast, 2020-2030 (V, U, W, L)
7 North America Precision Medicine Market
7.1 North America Precision Medicine Market by Country Revenue Forecast, 2020-2030
7.2 North America Precision Medicine Market Forecast by Therapeutics, 2020-2030
7.3 North America Precision Medicine Market Forecast by Technology, 2020-2030
7.4 North America Precision Medicine Market Forecast by End Users, 2020-2030
7.5 U.S.
7.5.1 Recovery Forecast, 2020-2030 (V, U, W, L)
7.6 Canada
7.6.1 Recovery Forecast, 2020-2030 (V, U, W, L)
8 Europe Precision Medicine Market by Country Revenue Forecast, 2020-2030
8.1 Europe Precision Medicine Market Forecast by Therapeutics, 2020-2030
8.2 Europe Precision Medicine Market Forecast by Technology, 2020-2030
8.3 Europe Precision Medicine Market Forecast by End Users, 2020-2030
8.4 Germany
8.4.1 Recovery Forecast, 2020-2030 (V, U, W, L)
8.5 France
8.5.1 Recovery Forecast, 2020-2030 (V, U, W, L)
8.6 UK
8.6.1 Recovery Forecast, 2020-2030 (V, U, W, L)
8.7 Italy
8.7.1 Recovery Forecast, 2020-2030 (V, U, W, L)
8.8 Spain
8.8.1 Recovery Forecast, 2020-2030 (V, U, W, L)
8.9 Belgium
8.9.1 Recovery Forecast, 2020-2030 (V, U, W, L)
8.10 Switzerland
8.10.1 Recovery Forecast, 2020-2030 (V, U, W, L)
8.11 Rest of Europe
8.11.1 Recovery Forecast, 2020-2030 (V, U, W, L)
9 Asia Pacific Precision Medicine Market by Country Revenue Forecast, 2020-2030
9.1 Asia Pacific Precision Medicine Market Forecast by Therapeutics, 2020-2030
9.2 Asia Pacific Precision Medicine Market Forecast by Technology, 2020-2030
9.3 Asia Pacific Precision Medicine Market Forecast by End Users, 2020-2030
9.4 Japan
9.4.1 Recovery Forecast, 2020-2030 (V, U, W, L)
9.5 China
9.5.1 Recovery Forecast, 2020-2030 (V, U, W, L)
9.6 India
9.6.1 Recovery Forecast, 2020-2030 (V, U, W, L)
9.7 Australia
9.7.1 Recovery Forecast, 2020-2030 (V, U, W, L)
9.8 Singapore
9.8.1 Recovery Forecast, 2020-2030 (V, U, W, L)
9.9 The Philippines
9.9.1 Recovery Forecast, 2020-2030 (V, U, W, L)
9.10 South Korea
9.10.1 Recovery Forecast, 2020-2030 (V, U, W, L)
9.11 Rest of Asia Pacific
9.11.1 Recovery Forecast, 2020-2030 (V, U, W, L)
10 Latin America Precision Medicine Market by Country Revenue Forecast, 2020-2030
10.1 Latin America Precision Medicine Market Forecast by Therapeutics, 2020-2030
10.2 Latin America Precision Medicine Market Forecast by Technology, 2020-2030
10.3 Latin America Precision Medicine Market Forecast by End Users, 2020-2030
10.4 Brazil
10.4.1 Recovery Forecast, 2020-2030 (V, U, W, L)
10.5 Mexico
10.5.1 Recovery Forecast, 2020-2030 (V, U, W, L)
10.6 Argentina
10.6.1 Recovery Forecast, 2020-2030 (V, U, W, L)
10.7 Rest of Latin America
10.7.1 Recovery Forecast, 2020-2030 (V, U, W, L)
11 Middle East and Africa Precision Medicine Market by Country Revenue Forecast, 2020-2030
11.1 Middle East and Africa Precision Medicine Market Forecast by Therapeutics, 2020-2030
11.2 Middle East and Africa Precision Medicine Market Forecast by Technology, 2020-2030
11.3 Middle East and Africa Precision Medicine Market Forecast by End Users, 2020-2030
11.4 UAE
11.4.1 Recovery Forecast, 2020-2030 (V, U, W, L)
11.5 Saudi Arabia
11.5.1 Recovery Forecast, 2020-2030 (V, U, W, L)
11.6 South Africa
11.6.1 Recovery Forecast, 2020-2030 (V, U, W, L)
11.7 Rest of Middle East and Africa
11.7.1 Recovery Forecast, 2020-2030 (V, U, W, L)
12 Leading Companies in the Precision Medicine Market
12.1 Abbott
12.1.1 Company Overview
12.1.2 Financials, 2015-2019 (US$ million, AGR %)
12.1.3 Products / Services
12.1.4 Mergers & Acquisitions (M&A) Activity
12.2 GE Healthcare
12.2.1 Company Overview
12.2.2 Financials, 2015-2019 (US$ million, AGR %)
12.2.3 Products / Services
12.2.4 Mergers & Acquisitions (M&A) Activity
12.3 Johnson & Johnson Services, Inc.
12.3.1 Company Overview
12.3.2 Financials, 2015-2019 (US$ million, AGR %)
12.3.3 Products / Services
12.3.4 Mergers & Acquisitions (M&A) Activity
12.4 Pfizer Inc.
12.4.1 Company Overview
12.4.2 Financials, 2015-2019 (US$ million, AGR %)
12.4.3 Products / Services
12.4.4 Mergers & Acquisitions (M&A) Activity
12.5 Laboratory Corporation of America Holdings
12.5.1 Company Overview
12.5.2 Financials, 2015-2019 (US$ million, AGR %)
12.5.3 Products / Services
12.5.4 Mergers & Acquisitions (M&A) Activity
12.6 Danaher
12.6.1 Company Overview
12.6.2 Financials, 2015-2019 (US$ million, AGR %)
12.6.3 Products / Services
12.6.4 Mergers & Acquisitions (M&A) Activity
12.7 Qiagen N.V.
12.7.1 Company Overview
12.7.2 Financials, 2015-2019 (US$ million, AGR %)
12.7.3 Products / Services
12.7.4 Mergers & Acquisitions (M&A) Activity
12.8 Thermo Fisher Scientific Inc.
12.8.1 Company Overview
12.8.2 Financials, 2015-2019 (US$ million, AGR %)
12.8.3 Products / Services
12.8.4 Mergers & Acquisitions (M&A) Activity
12.9 Illumina Inc.
12.9.1 Company Overview
12.9.2 Total Company Sales 2015-2019
12.9.3 Products / Services
12.9.4 Mergers & Acquisitions (M&A) Activity
12.10 Novartis AG
12.10.1 Company Overview
12.10.2 Total Company Sales, 2015-2018
12.10.3 Products / Services
12.10.4 Mergers & Acquisitions (M&A) Activity
12.11 GSK
12.11.1 Company Overview
12.11.2 Financials, 2015-2019 (US$ million, AGR %)
12.11.3 Products / Services
12.11.4 Mergers & Acquisitions (M&A) Activity
12.12 Merck KGaA
12.12.1 Company Overview
12.12.2 Financials, 2015-2019 (US$ million, AGR %)
12.12.3 Products / Services
12.12.4 Mergers & Acquisitions (M&A) Activity
12.13 F. Hoffmann-La Roche Ltd.
12.13.1 Company Overview
12.13.2 Financials, 2015-2019 (US$ million, AGR %)
12.13.3 Precision Medicine Products / Services
12.13.4 Mergers & Acquisitions (M&A) Activity
12.14 Amgen Inc.
12.14.1 Company Overview
12.14.2 Financials, 2015-2019 (US$ million, AGR %)
12.14.3 Products / Services
12.14.4 Mergers & Acquisitions (M&A) Activity
13 Conclusions and Recommendations
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A: About Visiongain
Appendix B: Visiongain report evaluation form
List of Tables
Table 1. Global Precision Medicine Market CAGR Forecast by Region 2020, 2025, 2030 (CAGR %)
Table 2. Key Benefits of Precision Medicine
Table 3. Key Elements of Precision Medicine
Table 4. Global Precision Medicine Market Forecast by Therapeutics (Pre-COVID-19), 2020-2030 (US$ billion, AGR %, CAGR %)
Table 5. Global Precision Medicine Market Forecast by Technology (Pre-COVID-19), 2020-2030 (US$ billion, AGR %, CAGR %)
Table 6. Global Precision Medicine Market Forecast by End Users (Pre-COVID-19), 2020-2030 (US$ billion, AGR %, CAGR %)
Table 7. Global Precision Medicine Market Forecast by Region (Pre-COVID-19), 2020-2030 (US$ billion, AGR %, CAGR %)
Table 8. Global Precision Medicine Market Forecast by Therapeutics, 2020-2030 (US$ billion, AGR %, CAGR %)
Table 9. Cancer Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 10. Cancer Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 11. Cancer Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 12. Cancer Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 13. Cancer Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 14. Cardiovascular Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 15. Cardiovascular Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 16. Cardiovascular Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 17. Cardiovascular Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 18. Cardiovascular Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 19. CNS Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 20. CNS Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 21. CNS Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 22. CNS Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 23. CNS Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 24. Infectious Diseases Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 25. Infectious Diseases Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 26. Infectious Diseases Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 27. Infectious diseases Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 28. Infectious Diseases Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 29. Immunology Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 30. Immunology Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 31. Immunology Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 32. Immunology Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 33. Immunology Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 34. Others Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 35. Others Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 36. Others Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 37. Others Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 38. Others Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 39. Global Precision Medicine Market Forecast by Technology, 2020-2030 (US$ billion, AGR %, CAGR %)



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ プレシジョンメディシンの世界市場2020-2030(Precision Medicine Market Report 2020-2030)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆